Julian Pardo

21PUBLICATIONS
90CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsMedical infection agents (incl. prions)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 04, 2026
Lytic IFNγ is stored in cytotoxic granules and coreleased with granzyme B to mediate cytotoxic T lymphocyte killing.

Xuemei Li, Claudia Schirra, Marie-Louise Wirkner

|Jan 13, 2026
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.

Cecilia Pesini, Mario Gil-Bellido, Lorena S Millan

|Mar 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression.

Anna Rea, Sara Santana-Hernández, Javier Villanueva

|Aug 29, 2024
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

Andrea Sesma, Julian Pardo, Dolores Isla

|May 23, 2024
The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo.

Konstantinos Kelepouras, Julia Saggau, Ana Beatriz Varanda

|Apr 30, 2024
Granzyme serine proteases in inflammation and rheumatic diseases.

Alexandre Aubert, Karen Jung, Sho Hiroyasu

Pageof 4

Frequent Collaborators

5 joint publications

Ariel Ramírez-Labrada

3 joint publications

Eva M Gálvez

3 joint publications

María Pilar Domingo

3 joint publications

Iratxe Uranga-Murillo